On May 30, 2023, Dov Pekelman, a director of Taro Pharmaceutical Industries Ltd. (Taro), submitted his resignation from the board of directors (the Board) of Taro to Taro's Chairman of the Board, Dilip Shanghvi. In doing so, Mr. Pekelman cited his age, his health, and his desire to reduce his business activities and obligations.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.42 USD | +0.28% | +0.55% | +1.53% |
May. 20 | Taro Pharmaceutical Industries Fiscal Q4 Earnings, Revenue Rise | MT |
May. 20 | Earnings Flash (TARO) TARO PHARMACEUTICAL INDUSTRIES Reports Q4 Revenue $164.9M, vs. Street Est of $156.1M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.53% | 1.59B | |
+34.35% | 705B | |
+31.18% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+14.77% | 238B | |
-3.60% | 210B | |
+10.14% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- TARO Stock
- News Taro Pharmaceutical Industries Ltd.
- Taro Pharmaceutical Industries Ltd. Announces Resignation of Dov Pekelman from the Board of Directors